Dehiscence of corticosteroid-induced abdominal striae in a 14-year-old boy treated with bevacizumab for recurrent glioblastoma

Journal of Child Neurology

Volumn 27, Issue 7, 2012, Pages 927-929

  Wheeler, Helen ^a   Black, Jason ^b   Webb, Suzanne ^b   Shen, Han ^c  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b CAIRNS BASE HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Anti vascular endothelial growth factor; Bevacizumab; Corticosteroids; Glioblastoma; Striae

Indexed keywords

BEVACIZUMAB; CORTICOSTEROID; DEXAMETHASONE; IRINOTECAN; LOMUSTINE; OPIATE; PROCARBAZINE; TEMOZOLOMIDE; VASCULOTROPIN;

ADOLESCENT; ANAMNESIS; ANGIOGENESIS; ARTICLE; BRAIN EDEMA; CANCER GROWTH; CASE REPORT; CHILD; COLLAGEN SYNTHESIS; DISEASE ACTIVITY; DISEASE COURSE; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG MECHANISM; DRUG MEGADOSE; DRUG WITHDRAWAL; GLIOBLASTOMA; HUMAN; INFLAMMATORY CELL; MALE; MULTIPLE CYCLE TREATMENT; NEUROLOGIC DISEASE; NEUTROPENIA; PRIORITY JOURNAL; RECURRENT CANCER; SCHOOL CHILD; SKIN PAIN; SKIN ULCER; STRIA; SYMPTOM; TREATMENT DURATION; TREATMENT OUTCOME; WOUND CARE; WOUND DEHISCENCE; WOUND HEALING;

ADOLESCENT; ADRENAL CORTEX HORMONES; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS, ALKYLATING; DACARBAZINE; DEXAMETHASONE; GLIOBLASTOMA; GLUCOCORTICOIDS; HUMANS; MALE; STRIAE DISTENSAE; SUPRATENTORIAL NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84862906450     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073811428007     Document Type: Article

References (20)

1. Plate KH, Mennel H. Vascular morphology and angiogenesis in glial tumors. Exp Toxicol Pathol. 1995 ; 47 (2-3). 89-94
2. Galicich JH, French L. Use of dexamethasone in the treatment of cerebral edema resulting from brain tumors and brain surgery. Am Pract Dig Treat. 1961 ; 12: 169-174
3. Ruderman N, Hall T. Use of glucocorticoids in the palliative treatment of metastatic brain tumors. Cancer. 1965 ; 18: 298-306
4. Kaal EC, Vecht C. The management of brain edema in brain tumors. Curr Opin Oncol. 2004 ; 16 (6). 593-600 (Pubitemid 39482980)
5. Yeo FE, Sawyers ES. Steroid-induced striae in severe nephrotic syndrome. Kidney Int. 2007 ; 72 (8). 1038 (Pubitemid 47530565)
6. Nigam PK. Striae cutis distensae. Int J Dermatol. 1989 ; 28 (7). 426-428
7. Euvrard S, Kanitakis J, Cochat P, Cambazard F, Claudy A. Skin diseases in children with organ transplants. J Am Acad Dermatol. 2001 ; 44 (6). 932-939 (Pubitemid 32493442)
8. Peters KB, Coyle TE, Vredenburgh JJ, Desjardins A, Friedman HS, Reardon DA. Ulceration of striae distensae in high-grade glioma patients on concurrent systemic corticosteroid and bevacizumab therapy. J Neurooncol. 2011 ; 101 (1). 155-159
9. Jain RK, di Tomaso E, Duda DG, Loeffler JS, Sorensen AG, Batchelor TT. Angiogenesis in brain tumours. Nat Rev Neurosci. 2007 ; 8 (8). 610-622 (Pubitemid 47093931)
10. Jain RK, Tong R, Munn LL. Effect of vascular normalization by anti-angiogenic therapy on interstitial hypertension, peri-tumor edema and lymphatic metastasis: insights from a mathematical model. Cancer Res. 2007 ; 67: 2729-2735 (Pubitemid 46548961)
11. Friedman HS, Prados MD, Wen PY, et al. Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol. 2009 ; 27 (28). 4733-4740
12. Kreisl TN, Kim L, Moore K, et al. Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma. J Clin Oncol. 2009 ; 27 (5). 740-745
13. Vredenburgh JJ, Desjardins A, Reardon DA, Friedman HS. Experience with irinotecan for the treatment of malignant glioma. Neuro Oncol. 2009 ; 11 (1). 80-91
14. Benesch M, Windelberg M, Sauseng W, et al. Compassionate use of bevacizumab (Avastin) in children and young adults with refractory or recurrent solid tumors. Ann Oncol. 2008 ; 19 (4). 807-813 (Pubitemid 351461055)
15. Glade Bender JL, Adamson PC, Reid JM, et al. Children's Oncology Group Study. Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: a Children's Oncology Group Study. J Clin Oncol. 2008 ; 26 (3). 399-405 (Pubitemid 351171691)
16. Liu AK, Macy ME, Foreman N. Bevacizumab as therapy for radiation necrosis in four children with pontine gliomas. Int J Radiat Oncol Biol Phys. 2009 ; 75 (4). 1148-1154
17. Narayana A, Kunnakkat S, Chacko-Mathew J, et al. Bevacizumab in recurrent high-grade pediatric gliomas. Neuro Oncol. 2010 ; 12 (9). 985-990
18. Oishi Y, Fu ZW, Ohnuki Y, Kato H, Noguchi T. Molecular basis of the alteration in skin collagen metabolism in response to in vivo dexamethasone treatment: effects on the synthesis of collagen type I and III, collagenase, and tissue inhibitors of metalloproteinases. Br J Dermatol. 2002 ; 147 (5). 859-868 (Pubitemid 35365431)
19. Vecht CJ, Hovestadt A, Verbiest HB, van Vliet JJ, van Putten WL. Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8, and 16 mg per day. Neurology. 1994 ; 44: 675-680 (Pubitemid 24129996)
20. Folkman J. Angiogenesis: an organizing principle for drug discovery?. Nat Rev Drug Discov. 2007 ; 6 (4). 273-286 (Pubitemid 46505878)